170 related articles for article (PubMed ID: 1566313)
1. Studies on a new antimalarial compound: pyronaridine.
Chang C; Lin-Hua T; Jantanavivat C
Trans R Soc Trop Med Hyg; 1992; 86(1):7-10. PubMed ID: 1566313
[TBL] [Abstract][Full Text] [Related]
2. Review of pyronaridine anti-malarial properties and product characteristics.
Croft SL; Duparc S; Arbe-Barnes SJ; Craft JC; Shin CS; Fleckenstein L; Borghini-Fuhrer I; Rim HJ
Malar J; 2012 Aug; 11():270. PubMed ID: 22877082
[TBL] [Abstract][Full Text] [Related]
3. Short report: effects of pyronaridine on gametocytes in patients with acute uncomplicated falciparum malaria.
Ringwald P; Meche FS; Basco LK
Am J Trop Med Hyg; 1999 Sep; 61(3):446-8. PubMed ID: 10497988
[TBL] [Abstract][Full Text] [Related]
4. Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa.
Ringwald P; Bickii J; Basco L
Lancet; 1996 Jan; 347(8993):24-8. PubMed ID: 8531545
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Pyronaridine-Artesunate for the Treatment of Uncomplicated
Han KT; Lin K; Han ZY; Myint MK; Aye KH; Thi A; Thapa B; Bustos MD; Borghini-Fuhrer I; Ringwald P; Duparc S
Am J Trop Med Hyg; 2020 Sep; 103(3):1088-1093. PubMed ID: 32524960
[TBL] [Abstract][Full Text] [Related]
6. Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial.
Poravuth Y; Socheat D; Rueangweerayut R; Uthaisin C; Pyae Phyo A; Valecha N; Rao BH; Tjitra E; Purnama A; Borghini-Fuhrer I; Duparc S; Shin CS; Fleckenstein L
PLoS One; 2011 Jan; 6(1):e14501. PubMed ID: 21267072
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays.
Kurth F; Pongratz P; Bélard S; Mordmüller B; Kremsner PG; Ramharter M
Malar J; 2009 Apr; 8():79. PubMed ID: 19389221
[TBL] [Abstract][Full Text] [Related]
9. Development of the new antimalarial drug pyronaridine: a review.
Chen C; Zheng X
Biomed Environ Sci; 1992 Jun; 5(2):149-60. PubMed ID: 1642789
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of oral pyronaridine for the treatment of acute uncomplicated falciparum malaria in African children.
Ringwald P; Bickii J; Basco LK
Clin Infect Dis; 1998 Apr; 26(4):946-53. PubMed ID: 9564481
[TBL] [Abstract][Full Text] [Related]
11. Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo.
Vivas L; Rattray L; Stewart L; Bongard E; Robinson BL; Peters W; Croft SL
Acta Trop; 2008 Mar; 105(3):222-8. PubMed ID: 18279817
[TBL] [Abstract][Full Text] [Related]
12. [In vitro sensitivity of Plasmodium falciparum isolates from China-Myanmar border region to chloroquine, piperaquine and pyronaridine].
Zhang CL; Zhou HN; Wang J; Liu H
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2012 Feb; 30(1):41-4. PubMed ID: 22913189
[TBL] [Abstract][Full Text] [Related]
13. Activity of pyronaridine and mepacrine against twelve strains of Plasmodium falciparum in vitro.
Elueze EI; Croft SL; Warhurst DC
J Antimicrob Chemother; 1996 Mar; 37(3):511-8. PubMed ID: 9182108
[TBL] [Abstract][Full Text] [Related]
14. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
[TBL] [Abstract][Full Text] [Related]
15. The antimalarial ferroquine: from bench to clinic.
Biot C; Nosten F; Fraisse L; Ter-Minassian D; Khalife J; Dive D
Parasite; 2011 Aug; 18(3):207-14. PubMed ID: 21894260
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of pyronaridine against African strains of Plasmodium falciparum.
Basco LK; Le Bras J
Ann Trop Med Parasitol; 1992 Oct; 86(5):447-54. PubMed ID: 1288425
[TBL] [Abstract][Full Text] [Related]
17. In Vitro Sensitivity of Pyronaridine in Thai Isolates of
Mahotorn K; Tan-Ariya P; Thita T; Ruang-Areerate T; Sittichot N; Suwandittakul N; Mungthin M
Am J Trop Med Hyg; 2018 Jan; 98(1):51-56. PubMed ID: 29141758
[TBL] [Abstract][Full Text] [Related]
18. Pyronaridine-artesunate combination therapy for the treatment of malaria.
Kurth F; Bélard S; Basra A; Ramharter M
Curr Opin Infect Dis; 2011 Dec; 24(6):564-9. PubMed ID: 21986615
[TBL] [Abstract][Full Text] [Related]
19. Chloroquine resistant malaria in children.
Memon IA; Kanth N; Murtaza G
J Pak Med Assoc; 1998 Apr; 48(4):98-100. PubMed ID: 9783043
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.
Price RN; Marfurt J; Chalfein F; Kenangalem E; Piera KA; Tjitra E; Anstey NM; Russell B
Antimicrob Agents Chemother; 2010 Dec; 54(12):5146-50. PubMed ID: 20876370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
